Society Testimony

Testimony to FDA on Rare Diseases

April 26, 2018

Testimony of the Endocrine Society Submitted to the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee

"Many endocrine conditions qualify as rare diseases as they affect fewer than 200,000 people each year, but patients lack effective treatments for many of these diseases. Although the FDA has approved more than 500 treatments since the passage of the Orphan Drug Act, only five percent of rare diseases have a treatment...Ongoing research to identify new treatments for many of these diseases could have a significant benefit to patients. The Society advocates for increased research funding for rare diseases and supports the FDA’s flexibility regarding clinical endpoints, patients sample sizes, and inclusion/exclusion criteria for clinical trials to increase our knowledge of rare diseases and to expand therapeutic options for treating these conditions..."

arrow Read the Full Testimony

Last Updated:

Policy Communications

Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

ENDO 2020

Maximize Your Savings

Register Today
Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Advance Registration Deadline: February 13, 2020

Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!